Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy Liu-Kreyche

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Pharmacology|May 20, 2011
In vitro assessment of cytochrome P450 inhibition and induction potential of tanespimycin and its major metabolite, 17-amino-17-demethoxygeldanamycinJinping Gan, Peggy Liu-Kreyche, W Griffith Humphreys
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 15, 2010
Metabolism of [2-14C]p-hydroxyphenyl acetic acid in rat, monkey and human hepatocytes and in bile-duct cannulated ratsLian Zhou, Peggy Liu-Kreyche, Ramaswamy A Iyer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2012
In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonistLian Zhou, Randy C Dockens, Peggy Liu-Kreyche, et al.
Frontiers in Pharmacology|August 6, 2019
Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor CellsPeggy Liu-Kreyche, Hong Shen, Anthony M Marino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2010
Disposition of [1'-(14)C]stavudine after oral administration to humansLian Zhou, Sanjeev Kaul, Peggy Liu-Kreyche, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 16, 2018
A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability studyLong Yuan, Christine Huang, Peggy Liu-Kreyche, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|May 20, 2011
In vitro assessment of cytochrome P450 inhibition and induction potential of tanespimycin and its major metabolite, 17-amino-17-demethoxygeldanamycinJinping Gan, Peggy Liu-Kreyche, W Griffith Humphreys
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 15, 2010
Metabolism of [2-14C]p-hydroxyphenyl acetic acid in rat, monkey and human hepatocytes and in bile-duct cannulated ratsLian Zhou, Peggy Liu-Kreyche, Ramaswamy A Iyer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2012
In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonistLian Zhou, Randy C Dockens, Peggy Liu-Kreyche, et al.
Frontiers in Pharmacology|August 6, 2019
Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor CellsPeggy Liu-Kreyche, Hong Shen, Anthony M Marino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2010
Disposition of [1'-(14)C]stavudine after oral administration to humansLian Zhou, Sanjeev Kaul, Peggy Liu-Kreyche, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 16, 2018
A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability studyLong Yuan, Christine Huang, Peggy Liu-Kreyche, et al.
Pageof 1